{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:55:23Z","timestamp":1793422523089,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2018-00239-ICMS"],"award-info":[{"award-number":["MYRG2018-00239-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0147\/2019\/A3"],"award-info":[{"award-number":["0147\/2019\/A3"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018602","name":"Guangxi Innovation-Driven Development Project","doi-asserted-by":"publisher","award":["GuiKe AA18118049"],"award-info":[{"award-number":["GuiKe AA18118049"]}],"id":[{"id":"10.13039\/501100018602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jare.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:56:47Z","timestamp":1623110207000},"page":"109-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"special_numbering":"C","title":["Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism"],"prefix":"10.1016","volume":"34","author":[{"given":"Songsong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiya","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0005","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1301\/nr.2007.jun.S57-S63","article-title":"Obesity and Nonalcoholic Fatty Liver Disease","volume":"65","author":"Angulo","year":"2007","journal-title":"Nutr Rev"},{"issue":"27","key":"10.1016\/j.jare.2021.06.001_b0020","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jare.2021.06.001_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jnutbio.2019.03.005","article-title":"Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD","volume":"69","author":"Liu","year":"2019","journal-title":"J Nutr Biochem"},{"issue":"10","key":"10.1016\/j.jare.2021.06.001_b0030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbalip.2019.05.016","article-title":"Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats","volume":"1864","author":"Tang","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.jare.2021.06.001_b0040","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jare.2021.06.001_b0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrgastro.2014.232","article-title":"NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD","volume":"12","author":"Rinella","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2021.06.001_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109915","article-title":"Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis","volume":"124","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2021.06.001_b0065","first-page":"9","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2020","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.jare.2021.06.001_b0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molmed.2007.06.001","article-title":"Targeting farnesoid X receptor for liver and metabolic disorders","volume":"13","author":"Fiorucci","year":"2007","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jare.2021.06.001_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molmet.2019.08.019","article-title":"PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease","volume":"29","author":"Rana","year":"2019","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jare.2021.06.001_b0090","first-page":"11","article-title":"BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis","volume":"43","author":"Peter","year":"2002","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","article-title":"FXR signaling in metabolic disease","volume":"582","author":"Zhang","year":"2008","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2005.01.141","article-title":"Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor","volume":"329","author":"Savkur","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2008-1040410","article-title":"Function and Regulation of Hydroxylases Involved in the Bile Acid Biosynthesis Pathways","volume":"12","author":"Vlahcevic","year":"1992","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0033-1358520","article-title":"Bile acid-mediated control of liver triglycerides","volume":"33","author":"Fuchs","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0115","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0120","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2021.06.001_b0125","first-page":"12","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","author":"Watanabe","year":"2004","journal-title":"J Clin Invest (10)"},{"key":"10.1016\/j.jare.2021.06.001_b0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jff.2017.11.048","article-title":"Polyphenol-rich extract from wild Lonicera caerulea berry reduces cholesterol accumulation by mediating the expression of hepatic miR-33 and miR-122, HMGCR, and CYP7A1 in rats","volume":"40","author":"Liu","year":"2018","journal-title":"J Funct Foods"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0135","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jare.2021.06.001_b0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor","volume":"89","author":"Michael","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jare.2021.06.001_b0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jep.2013.02.029","article-title":"Identification of the major metabolites of hyperoside produced by the human intestinal bacteria using the ultra performance liquid chromatography\/quadrupole-time-of-flight mass spectrometry","volume":"147","author":"Yang","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4314\/tjpr.v16i2.30","article-title":"Pharmacological activities and pharmacokinetic study of hyperoside: A short review","volume":"16","author":"Raza","year":"2017","journal-title":"Trop J Pharm Res"},{"issue":"9","key":"10.1016\/j.jare.2021.06.001_b0160","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/acs.jproteome.6b00601","article-title":"Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD","volume":"15","author":"Li","year":"2016","journal-title":"J Proteome Res"},{"issue":"7","key":"10.1016\/j.jare.2021.06.001_b0165","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1096\/fj.14-250555","article-title":"The human liver-specific proteome defined by transcriptomics and antibody-based profiling","volume":"28","author":"Kampf","year":"2014","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.23271","article-title":"Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease","volume":"51","author":"Bell","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jare.2021.06.001_b0175","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11596-019-1997-3","article-title":"Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3\/AMPK\/ACC Pathway","volume":"39","author":"Zhang","year":"2019","journal-title":"Curr Med Sci"},{"issue":"10","key":"10.1016\/j.jare.2021.06.001_b0185","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1074\/mcp.M114.038786","article-title":"Proteomic analysis of solid pseudopapillary tumor of the pancreas reveals dysfunction of the endoplasmic reticulum protein processing pathway","volume":"13","author":"Zhu","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clnu.2019.02.037","article-title":"Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial","volume":"39","author":"Wan","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jare.2021.06.001_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110053","article-title":"Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice","volume":"126","author":"Liu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0200","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jcb.21077","article-title":"Acetyl-coenzyme A carboxylases: versatile targets for drug discovery","volume":"99","author":"Tong","year":"2006","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijmm.2016.2831","article-title":"Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK\/ACC in high-fat diet-fed mice","volume":"39","author":"Kawaguchi","year":"2017","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12906-019-2671-9","article-title":"Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells","volume":"19","author":"Fang","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.1138104","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR","volume":"18","author":"Zhang","year":"2004","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11883-015-0500-2","article-title":"FXR agonists as therapeutic agents for non-alcoholic fatty liver disease","volume":"17","author":"Carr","year":"2015","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0225","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/liv.14423","article-title":"Absence of Bsep\/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice","volume":"40","author":"Fuchs","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jare.2021.06.001_b0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12072-009-9137-y","article-title":"The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression","volume":"3","author":"Enjoji","year":"2009","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0036-1571296","article-title":"Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease","volume":"36","author":"Fuchs","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0240","first-page":"11","article-title":"Alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"HIPPOKRATIA"},{"key":"10.1016\/j.jare.2021.06.001_b0245","first-page":"13","article-title":"Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein","volume":"42","author":"Francisco Blanco-Vaca","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jare.2021.06.001_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117601","article-title":"ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK\/mTOR mediated autophagy","volume":"252","author":"Lu","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0255","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-020-16918-x","article-title":"Hepatic HuR modulates lipid homeostasis in response to high-fat diet","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jare.2021.06.001_b0260","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1074\/jbc.M116.765917","article-title":"APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice","volume":"292","author":"Cheng","year":"2017","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jare.2021.06.001_b0265","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jare.2021.06.001_b0270","first-page":"8","article-title":"Genetic cholestasis, causes and consequences for hepatobiliary transport","volume":"23","author":"Peter","year":"2003","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jare.2021.06.001_b0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.jare.2021.06.001_b0280","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1021\/jf5063606","article-title":"Cholesterol-Lowering Activity of Sesamin Is Associated with Down-Regulation on Genes of Sterol Transporters Involved in Cholesterol Absorption","volume":"63","author":"Liang","year":"2015","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jare.2021.06.001_b0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2013.02.005","article-title":"From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport","volume":"75","author":"D\u00e1valos","year":"2013","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.jare.2021.06.001_b0290","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jare.2021.06.001_b0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Yu","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0300","first-page":"128","article-title":"Hypoxic liver injury and cholestasis in critically ill patients","volume":"19","author":"Horvatits","year":"2013","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"10.1016\/j.jare.2021.06.001_b0305","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"issue":"3","key":"10.1016\/j.jare.2021.06.001_b0315","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/ijms17030300","article-title":"Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics","volume":"17","author":"He","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2021.06.001_b0320","first-page":"12","article-title":"The Continuing Importance of Bile Acids in Liver and Intestinal Disease","volume":"159","author":"Alan","year":"1999","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jare.2021.06.001_b0325","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jare.2021.06.001_b0330","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gutjnl-2012-302945","article-title":"Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice","volume":"62","author":"Uriarte","year":"2013","journal-title":"Gut"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:50:20Z","timestamp":1761857420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123221000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":66,"alternative-id":["S2090123221000977"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2021.06.001","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/).","name":"copyright","label":"Copyright"}]}}